Experts at last week's BIO meeting in Philadelphia discussed the long-term implications of many gene therapies hitting the market, and ways their prices could be lowered so they'd be more cost-effective.
Can we think of a less innovative word these days than "innovative?" BIO doesn't seem to care, given its hackneyed new name change.
PurpleLab® stands out from others in this sector by providing its data analytics services to several different groups of users across healthcare and pharma companies.
More evidence that Minnesota has a lot of work to do in developing a viable biotech industry. From 2004 to 2009, local human biotech firms attracted only $1 million in venture capital compared to $1.2 billion for medical devices, according to a report by Battelle Memorial Institute and the Biotechnology Industry Organization. $1 million over […]
The Biotechnology Industry Organization international convention returns to Chicago this week — a nod to the importance of pharmaceutical and therapeutic companies in Midwestern states like Ohio. Drugmaking has history in Ohio. From Procter & Gamble Pharmaceuticals (NYSE: PG) in Cincinnati (sold last year to Irish drug company Warner Chilcott), to generic drugmakers Ben Venue […]
University/industry research and development partnerships added $187 billion to the U.S. economy from 1996 to 2007, according to a Biotechnology Industry Organization study of the affects of the Bayh-Dole Act.
So is the nation's biotechnology industry booming or a bust? It all depends on where you are.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Even the "recession-proof" health care and biotechnology industries are feeling the economic pain of the worst contraction since The Big One. Will consumers keep the health care industry growing?